https://www.pharmanow.live/latest-news/fda-oha-guidance-combination-products-rare-disease-regulatory-expectations 2026-11-06T22:59:58+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA Office of Health Advancement Issues Guidance Shaping Regulatory Expectations FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2d8cc816-fa8f-4c93-b565-b5b2b2be3535/3155fe28-0fcc-4e40-b279-28092e4a2f37.png https://www.pharmanow.live/latest-news/moderna-mrna-ebola-vaccine-phase-2-3-dr-congo 2026-11-06T23:01:37+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Moderna Achieves Phase 2/3 Recommendation for mRNA Ebola Vaccine Moderna https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/34b3dc96-0699-4769-b328-f1b9976ed1ac/270b372e-5749-49ca-bc55-16b8e1514faf.png https://www.pharmanow.live/latest-news/maat-pharma-picasso-trial-maat013-metastatic-melanoma-safety-endpoint 2026-11-06T23:03:19+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 MaaT Pharma Achieves Primary Safety Endpoint in PICASSO Trial MaaT https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.maatpharma.com/wp-content/uploads/2021/12/MAAT_emblem_colored_large-e1641229370236.png https://www.pharmanow.live/latest-news/fda-2024-anda-approvals-720-generic-pricing-pressure 2026-11-06T23:13:20+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA Publishes 2024 ANDA Data Showing 720 Approvals Amid Sustained Generic Pricing Pressure FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/ddc780db-85ce-47fe-a1a7-810968a9ddda.png https://www.pharmanow.live/latest-news/rigel-pharmaceuticals-launches-veppanu-first-fda-approved-protac-therapy-metastatic-breast-cancer 2026-11-06T23:10:18+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Rigel Pharmaceuticals Launches VEPPANU as First FDA-Approved PROTAC Therapy Rigel https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/9d29197a-9a02-4cbc-bc11-ac03ba39a697.png https://www.pharmanow.live/latest-news/janssen-fda-accelerated-approval-rybrevant-faspro-hnscc 2026-11-06T23:11:17+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Janssen Gains FDA Accelerated Approval for Rybrevant Faspro Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/cd14d4ba-93b9-4530-9ca5-2a961c946d4f.png https://www.pharmanow.live/latest-news/cabaletta-bio-targets-1q28-bla-submission-rese-cel-cart-manufacturing 2026-11-06T23:09:05+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Cabaletta Bio Targets 1Q28 BLA Submission for Rese-cel Cabaletta https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/50345755-46be-4ea6-9567-acf8dbce1b61.png https://www.pharmanow.live/latest-news/allogene-therapeutics-alpha3-enrollment-asia-pacific-expansion-lbcl 2026-11-06T23:15:46+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Allogene Therapeutics Advances ALPHA3 Enrollment Globally with Expansion in 1L LBCL Trial Allogene https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/b0fb52a6-01fb-45d5-a5bf-7d2e5358a4c9.png https://www.pharmanow.live/latest-news/lantheus-merges-curium-8-billion-deal-dual-fda-approvals 2026-11-06T22:55:18+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Lantheus Merges with Curium in $8 Billion Deal After Dual FDA Approvals Lantheus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.globenewswire.com/newsroom/ti?nf=OTg3MDc4MiM3OTQ2Mjc2IzIwMDc2OTA= https://www.pharmanow.live/latest-news/fda-launches-rare-disease-framework-initiative-orphan-drug-review 2026-11-06T22:56:33+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA Launches Rare Disease Framework Initiative to Reshape Orphan Drug Review Pathways FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/6d576d78-51ae-4600-a479-fd602da8b870.png https://www.pharmanow.live/latest-news/viatris-acquires-pacira-biosciences-regulatory-approvals-innovative-medicines-pivot 2026-11-06T13:01:20+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Viatris Advances Pacira Acquisition as Innovative Medicines Pivot Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/viatris-pacira-acquisition-regulatory-approvals-innovative-medicines-strategy-202620261106130109.webp https://www.pharmanow.live/latest-news/telix-pharmaceuticals-joins-thera4care-consortium-tlx400-tx-fap-targeting-theranostics-europe 2026-11-06T12:53:10+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Telix Joins Thera4Care Consortium to Advance FAP-Targeted Therapy Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/telix-thera4care-consortium-tlx400-tx-terbium-161-fap-theranostics-202620261106125146.webp https://www.pharmanow.live/latest-news/bayer-gains-china-first-line-approval-sevabertinib-her2-mutated-advanced-lung-cancer 2026-11-06T12:46:03+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Bayer Wins China First-Line Approval for Sevabertinib in NSCLC Bayer https://www.pharmanow.live/latest-news/evotec-secures-vertex-commercial-manufacturing-deal-povetacicept-jpod-redmond 2026-11-06T12:25:40+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Evotec Wins Vertex Commercial Manufacturing Role for Povetacicept Evotec https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/evotec-vertex-povetacicept-commercial-manufacturing-jpod-redmond-202620261106122406.webp https://www.pharmanow.live/latest-news/alembic-pharma-difgen-partnership-us-complex-generics 2026-11-06T12:14:59+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Alembic Expands DifGen Partnership for US Complex Generics Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alembic-difgen-partnership-us-complex-generics-20-products-202620261106121415.webp https://www.pharmanow.live/latest-news/fresenius-wuxi-biologics-deal-biosimilar-pipeline-66-molecules 2026-11-06T12:00:57+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Fresenius Teams With WuXi on 66-Molecule Biosimilar Pipeline Fresenius https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fresenius-wuxi-biologics-biosimilar-pipeline-66-molecules-202620261106120048.webp https://www.pharmanow.live/latest-news/oryzon-iadademstat-phase-ib-aml-ash-2026-phase-iii-pivot 2026-11-06T11:48:44+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Oryzon Reports 95% ORR in Phase Ib AML Trial Ahead of Phase III Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-iadademstat-95-percent-orr-phase-ib-aml-trial-ash-202620261106114821.webp https://www.pharmanow.live/latest-news/merck-launches-phase-3-trial-ohtuvayre-copd-exacerbations 2026-11-06T11:43:43+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Merck Launches Phase 3 OHTUVAYRE Trial for COPD Exacerbations Merck https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/merck-ohtuvayre-enhance-3-phase-3-copd-exacerbation-trial-202620261106114120.webp https://www.pharmanow.live/latest-news/medicus-pharma-spac-loi-skinject-135-million-business-combination 2026-11-06T11:34:32+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Medicus Proposes $135M SkinJect Business Combination With SPAC Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/medicus-pharma-skinject-135-million-spac-business-combination-202620261106112654.webp